Digital Healthcare Partnerships Offer Expedited Development Potential with Novartis' interest Reinforcing the Potential of its Pharmaceutical Pipeline and Portfolio - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Medical Industry Week Issue 790" report to their offering.

Novartis' interest in the digital healthcare/medical device field will reinforce the potential of its pharmaceutical pipeline and portfolio. The utilisation of tools to expedite drug development is commonplace, and new methods to achieve this goal will continue to be explored. Novartis is early in its adoption of digital healthcare partnerships, and other pharmaceutical firms will follow suit as the digital healthcare market develops.

Key Topics Covered:

1. Agreement News

  • Interface Biologics/Fresenius Medical Extend Endexo Licensing Deal
  • Fraunhofer ITEM Acquires CPA Technology Assets From Takeda
  • Second Sight/Tecnosalud Enter Distribution Deal For Argus II System In Argentina
  • RTI Enters Deal With Oxford Performance Materials

2. Corporate News

  • Hemovent Completes Fundraising
  • Regentis Raises Funds To Support GelrinC Clinical Development
  • Stryker's M&A Reflects Shifting Industry Trends
  • D-EYE Srl Secures Funding To Advance Smartphone-Based Retinal Imaging System
  • Mölnlycke Acquires Sundance Solutions

3. Financial News

  • International Presence Dampens Becton Dickinson's Revenues
  • Terumo Domestic Woes Tempered By International Growth
  • NuVasive's Growth To Continue In FY

4. Product News

  • FDA Clears LifeWatch's Continuous Vital Signs Monitoring Service
  • FDA Clears CorMatrix Tyke Implantable Cardiac Device For Paediatric Patients
  • ForaCare Launches 3G Fora DUO Ultima D40g
  • COFEPRIS To Improve Third-Party Review Process For Medical Devices
  • NICE Recommends Medtronic's MiniMed Paradigm Veo System To Treat Type I Diabetes
  • FDA Clears Philips' Expression MR400 Patient Monitoring Technology
  • NobleStitch EL Approved In Kazakhstan To Treat PFO Closures
  • Valtech's Cardioband Mitral Reconstruction System Granted Reimbursement In Germany
  • Reimbursement Provides Favourable LAAC Market Conditions
  • FDA Clears MXO's dynaMX Compression Staple
  • Wenzel Spine's VariLift-LX Interbody Device Granted FDA Marketing Green Light
  • Cook Medical Recalls Select Lots Of Catheters And Pressure Monitoring Sets
  • EndoChoice Releases Lumos Adaptive Matrix Imaging Software
  • Biotronik's Itrevia 7 HF-T CRT-D Approved For Full-Body MRI Scanning In Japan
  • Drager's Oxylog Ventilators Recall Marked As Class I
  • FDA Clears Zimmer Biomet's Unite3D Bridge Fixation System
  • Chemence Medical's Exofin Tissue Adhesive Granted FDA Clearance
  • Optovue's AngioVue System Secures FDA Marketing Green Light
  • Recalls Decline Despite Device Scrutiny Increasing

For more information visit http://www.researchandmarkets.com/research/l86rrz/medical_industry

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare